
Keywords: ERT; enzyme replacement therapy; ACP; acid phosphatase; ACE; angiotensin converting enzyme; GC; Gaucher cells; GD2; Gaucher disease Type 2; Neuronopathic Gaucher disease; Pulmonary involvement; Myelodysplastic syndrome; Autopsy; CD68 immune staining;